Understanding if and how can Risperdal be given IM?
•
3 min read
Medication non-adherence is a major challenge in treating chronic psychiatric conditions like schizophrenia, with estimates suggesting as many as 40% of outpatients are at least partially non-adherent with oral medication. For this reason, a long-acting injectable (LAI) formulation of risperidone, known as Risperdal Consta, was developed and can indeed be given IM. This formulation addresses adherence issues by requiring administration only once every two weeks.